Read the complete Provisional Clinical Opinion (PCO) from ASCO, which recommends that there is insufficient evidence to recommend routine screening for chronic HBV infection in all patients with cancer who are about to receive or are currently receiving cytotoxic chemotherapy or immunosuppressive therapy: http://www.asco.org/pco/hepb
|
| |